Viage Therapeutics
Viage Therapeutics is a biotech company, founded in 2018.
- Founded
- 2018
- Business Model
- B2B
- Website
- viagetx.com
About
Viage Therapeutics develops neurotherapeutics targeting the gut-brain axis. Its clinical candidate, DGX-001, is an oral drug designed to modulate the vagus nerve through receptor interactions on enteroendocrine cells in the gut, regulating brain cell activity. Its pipeline includes peptides and small molecules with potential applications in cognitive impairment, depression, anxiety, and inflammatory disease.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Calico researches human aging using advanced technologies and model systems, applying that knowle...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/viage-therapeutics"><img src="https://indexed.vc/api/badge/company/viage-therapeutics" alt="Viage Therapeutics on Indexed.vc" width="260" height="76" /></a>